Plasma levels of von Willebrand factor antigen in acute bronchitis and in a normal population

Respiratory Medicine

Volumn 92, Issue 3, 1998, Pages 395-400

  Boldy, D A R ^a   Short, P E ^b   Cowen, P ^c   Hill, F G H ^b   Chambers, D C ^a   Ayres, J G ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c W Midlands Reg Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; C REACTIVE PROTEIN; VON WILLEBRAND FACTOR;

ACUTE PHASE RESPONSE; ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BRONCHITIS; CELL DAMAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENERAL PRACTICE; HUMAN; LUNG CIRCULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPIROMETRY; SYSTEMIC CIRCULATION; TIME;

EID: 0031955626     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90281-5     Document Type: Article

References (46)

1. Kwast TH, Stel HV, Cristen E, Bertina RM, Veerman CI. Localization of factor VIII-procoagulant antigen: an immunohistological survey of the human body using monoclonal antibodies. Blood 1986; 67: 222-227.
2. Christophe O, Ribba AS, Baruch D et al. Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor. Blood 1994; 83: 3553-3561.
3. Girma JP, Meyer D, Verweij CL, Pannekoek H, Sixma JJ. Structure-function relationship of human von Willebrand factor. Blood 1987; 70: 605-611.
4. Geggel RL, Carvalho CA, Hoyer LW, Reid LM. Von Willebrand factor abnormalities in primary pulmonary hypertension. Am Rev Respir Dis 1987; 135: 294-299.
5. Lopes AAB, Maeda NY. Abnormal degradation of von Willebrand factor main subunit in pulmonary hypertension. Eur Respir J 1995; 8: 530-536.
6. Rabinovitch M, Andrew M, Thorn H et al. Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects. Circulation 1987; 76: 1043-1052.
7. Pedrinelli R, Giampietro O, Carmassi F et al. Microalbuminaria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-18.
8. Blann AD, Naqvi T, Waite M, McCollum CN. Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993; 7: 107-111.
9. Penny WF, Weinstein M, Salzman EW, Ware JA. Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics. Circulation 1991; 83: 1630-1636.
10. Duffy A, Blann AD, Anderson J, Miller P, Gowlands E, McCollom CN. Increased von Willebrand factor antigen in familial hypercholesterolaemia with or without vascular disease. Atherosclerosis 1991; 90: 226.
11. Bartsch P, Haebedi A, Franciolli M, Kruithof EKO, Straub PW. Coagulation and fibrinolysis in acute mountain sickness and beginning pulmonary oedema. J Appl Physiol 1989; 66: 2136-2144.
12. Pottinger BE, Read RC, Paleolog EM, Higgins PG, Pearson JD. Von Willebrand factor is an acute phase reactant in man. Thromb Res 1989; 53: 387-394.
13. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995; 90: 244-248.
14. Tannenbaum SH, Gralnick HR. γ-Interferon modulates von Willebrand factor release by cultured human endothelial cells. Blood 1990; 75: 2177-2184.
15. Jones DK, Perry EM, Grosso MA, Voelkel NF. Release of von Willebrand factor antigen (vWF:Ag) and eicosanoids during acute injury to the isolated rat lung. Am Rev Respir Dis 1992; 145: 1410-1415.
16. Rubin DB, Wiener-Kronish JP, Murray JF et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86: 474-480.
17. Sabharwal AK, Bajaj SP, Ameri A et al. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Respir Crit Care Med 1995; 151: 758-767.
18. Carvalho ACA, Bellman SM, Saullo VJ, Quinn D, Zapol W. Altered factor VIII in acute respiratory failure. NEJM 1982; 307: 1113-1119.
19. Matucci-Cerinic M, Pignone A, Iannone F et al. Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: a longitudinal study of plasma ACE level, endothelial injury and lung involvement. Respir Med 1990; 84: 283-287.
20. Blann AD, Illingworth K, Jayson MIV. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993; 20: 1325-1330.
21. Jones DK, Luddington R, Higenbottam TW et al. Changes in Factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage. Thromb Haemost 1988; 60: 199-204.
22. Jones DK. Markers for impending adult respiratory distress syndrome. Respir Med 1990; 84: 89-91.
23. Moalli R, Doyle JM, Tahhan HR, Hasan FM, Braman SS, Saldeen T. Fibrinolysis in critically ill patients. Am Rev Respir Dis 1989; 140: 287-293.
24. Jansson J, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351-355.
25. Nachman RL, Jaffe EA. Subcellular platelet Factor VIII antigen and von Willebrand factor. J Exp Med 1975; 141: 1101-1113.
26. Boldy DAR, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med 1990; 84: 377-385.
27. American Thoracic Society. Definitions and classifications of infectious reactions of the lung. Am Rev Respir Dis 1970; 101: 116-150.
28. Short PE, Williams CE, Picken AM, Hill FGH. Factor VIII related antigen: an improved enzyme immunoassay. Med Lab Sci 1982; 39: 351-355.
29. Enayat MS, Hill FGH. Analysis of the complexity of the multimeric structure of Factor VIII related antigen/ von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 1983; 36: 915-919.
30. Bland JM, Altman DG. Measurement error. BMJ 1996; 313: 744.
31. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988; 43: 265-267.
32. Prentice CRM, Forbes CD, Smith SM. Rise of Factor VIII after exercise and adrenaline infusion, measured by immunological and biological techniques. Thromb Res 1972; 1: 493-506.
33. Stibbe J. Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (von Willebrand factor) and F VIII-Agn, but disproportional increase of F VIII-AHF. Thromb Res 1977; 10: 163-168.
34. Belch JJF, McArdle BM, Burns P, Lowe GDO, Forbes CD. The effects of acute smoking on platelet behaviour, fibrinolysis and haemorrheology in habitual smokers. Thromb Haemost 1984; 51: 6-8.
35. Ingram GIC, Jones RV, Hershgold EJ, Denson KWE, Perkins JR. Factor-VIII activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation. Br J Haematol 1977; 35: 81-100.
36. Brozovic M. Physiological mechanisms in coagulation and fibrinolysis. Br Med Bull 1977; 33: 231-238.
37. Meade TW, North WRS. Population-based distributions of haemostatic variables. Br Med Bull 1977; 33: 283-288.
38. Chakrabati R, Brozovic M, North WRS, Stirling Y, Meade TW. Effects of age on fibrolytic activity and Factors V, VII and VIII. Proc Roy Soc Med 1975; 68: 15-16.
39. Pepys MB. The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. The Oxford Textbook of Medicine, 3rd edn. Oxford: Oxford University Press, 1996, pp. 1527-1533.
40. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 51: 81-88.
41. Trautwein C, Boker K, Manns MP. Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms. Gut 1994; 35: 1163-1166.
42. McCarthy PL, Frank AL, Ablow RC, Masters SJ, Dolan TF. Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia. J Paediat 1978; 92: 454-456.
43. Peltola HO. C-reactive protein for rapid monitoring of infections of the central nervous system. Lancet 1982; 1 (8279); 980-982.
44. McCord FB, Jenkins JG, Lim JHK. C-reactive protein concentration as screening test for bacterial infection in febrile children. BMJ 1985; 291: 1685-1686.
45. Cucuianu MP, Cristea A, Roman S, Rus H, Missits I, Pechet L. Comparative behaviour of the components of the Factor VIII complex in acute myocardial infarction. Thromb Res 1983; 30: 487-497.
46. Giustolisi R, Musso R, Cacciola E, Cacciola RR, Russo M, Petrialito A. Abnormal plasma levels of Factor VIII/von Willebrand factor complex in myocardial infarction - expression of acute phase reaction or index of vascular endothelium damage? Thromb Haemostat 1984; 51: 408.